Introduction {#sec1-1}
============

Vietnamese, as well as the Asian people, belongs to skin types III-V (Fitzpatrick skin type). However, melasma, freckles, and lentigines are the epidermal disorders commonly seen \[[@ref1]\].

Freckles are typical pigmentation disorders presenting by hyperpigmentation dark -- brown or light -- circular brown spots on face, especially on the cheeks. Freckles should be distinguished from lentigines \[[@ref2]\]. Lentigines are well-circumscribed, small, brown spots which appear both on sun-exposed and no exposed areas \[[@ref3]\], \[[@ref4]\]. Freckles can appear on all types of skin tones \[[@ref2]\], \[[@ref5]\].

Several treatments effectively diminish the appearance of freckles. Some of the treatments include skin-lightening creams such as hydroquinone, prescription medications containing retinoid, chemical peels that are shown to improve pigmentation irregularities, IPL therapy \[[@ref6]\] and others pigment lasers \[[@ref7]\], \[[@ref8]\], \[[@ref9]\]. Alex TriVantage is a q-switched laser which is built upon the proven performance of 755 nm, Q-switched Alexandrite laser with the addition of 1064 nm and 532 nm, Q-switched Nd: YAG wavelengths. With the 755 nm Long-Pulse mode, it is used for treating a wide variety of epidermal and subdermal pigmented lesions safely. The acquirement of freckles treatment is recently increased in Vietnam and many medical facilities in our country in the past few years applied the different pigment lasers in treating pigmentary disorders.

Our study aimed to assess the effectiveness of Alex TriVantage laser on freckles treatment at Hanoi Hospital of Dermatology and Venereology (HHDV).

Patients and Methods {#sec1-2}
====================

The prospective controlled clinical trial on 30 patients with freckles treated by QS Alexandrite laser at HHDV. Informed consent was obtained from the patients before the laser treatment. Photographs were taken before treatment. The treated areas were numbed with topical anaesthesia using EMLA 5% cream. Eyes of patients were protected with specific protective glasses. In all cases, test spots were done, and the results were checked after 1 month to determine the parameters before performing the laser treatment on the entire area.

The used laser machine was an AlexTriVantage of Candela company -- the USA, wavelength 755 nm. The patients have treated 2 sections with power 5.0-6.0 j/cm^2^; spot size 3 mm, at week 0 and week 4. Ice packs were applied to the treated areas to reduce erythema and oedema.

After these procedures, all patients were asked to avoid unnecessary sun exposure. None combination treatment was indicated after the laser treatment once the scabs had fallen off along with daytime use of sunscreen. The final results were analysed after 4, 8 and 12 weeks after treatment. The colour of the lesion was assessed by using colour to Von Luschan's chromatic scale:

Grade 1: same skin colour with normal skin;Grade 2: light pigmentation (scale 19-24);Grade 3: medium pigmentation (scale 25-27);Grade 4: hyperpigmentation (scale 28-32);Grade 5: very high pigmentation (scale 33-36).

The results were evaluated based on the improvement of the lesion colour before and at 4, 8 and 12 weeks after treatment with very good improvement, if colour of lesion improved ≥ 3 scales or the lesion, becomes normal skin; good improvement if colour of lesion improved ≥ 2 scales and no improvement if the colour of lesion improved less than 1 scale.

We also analysed the improvement of the lesion colour by Visia^®^ complex analysis system. The Canfield Imaging Systems was used for capturing multi-spectral photos of the face. Brown spot index was calculated and analysed at pre- and post-treatment by digital images technologies (BS-320 facial skin analysis)

The side-effects including hyperpigmentation, hypopigmentation, scars, were reported. The data was collected and analysed by SPSS 16.0.

Results {#sec1-3}
=======

Thirty female patients were recruited for the study. Almost all of them were female (96.7%). Nine of patients (30%) were less than 30 years old, and 11 (70%) of them were older than 30 years old as shown in Tablet. All of them were finished at 2 sections of treatment, and no patients were needed in the third section. In overalls, the good and very good levels were noted in 63.3% of patients; there was 26.7 % of them had partial improvement. Brown spots index before and after treatment were 39.13 ± 20.66 and 54.23 ± 16.78 (p \< 0.001; respectively); and after 12-weeks, there were no recurrences as shown in [Table 2](#T1 T2){ref-type="table"} and [Figure 1](#F1){ref-type="fig"}

###### 

Characteristics of study subjects

                                               n    \%
  -------------------------------------------- ---- ------
  Sex                                               
   Female                                      29   96.7
   Male                                        1    3.3
  Age                                               
   11-≤20                                      3    10
   21-≤30                                      6    20
   31-≤40                                      15   50
   41-≤50                                      4    13.3
   \>50                                        2    6.7
  Skin type                                         
   III                                         11   36.7
   IV                                          19   63.3
  Severity (Basing on the number of lesions)        
   \<100                                       4    13.3
   \>100                                       26   86.7

###### 

The effectiveness of QS Alexandrite laser on freckles treatment *(n = 30)*

                                 Improvement               
  ------------------------------ ------------- ----------- -----------
  Age (years old)                \< 30         7 (23.3)    2 (6.7)
  \> 30                          12 (40.0)     9 (30.0)    
  Skin Type                      III           10 (33.3)   1 (3.3)
  (Fitzpatrick classification)   IV            9 (30.1)    10 (33.3)
  Location                       Chin          6 (20.0)    1 (3.3)
  forehead                       2 (6.7)       2 (6.7)     
  Check, nose                    11 (36.7)     8 (26.6)    
  Total                                        19 (63.3)   11 (26.7)

![A 19 years old woman before and after 2 sections of treatment by QS Alexandrite A); Brown spots index before was -35.5 and +7 after treatment B)](OAMJMS-7-287-g001){#F1}

The improvement of lesions on patients with skin type III was higher than that on patients with type IV skin; however, the statistic was not significant. The result was not also different between the location of the lesions as well as of the age of the patients as shown in [Table 2](#T2){ref-type="table"}.

The Brown index before and after treatment are 39.13 ± 2066 and 54.23 ± 16, 78 (p \< 0,005; test T student).

Investigating side effects, we noted that 2 patients had hyperpigmentation post laser treatment, accounting for 6.7%. No patients suffered from hypopigmentation and scars as shown in [Table 3](#T3){ref-type="table"}.

###### 

The unwanted effects after QS Alexandrite treatment

  Unwanted effects    n    \%
  ------------------- ---- ------
  Hyperpigmentation   2    6.7
  Hypopigmentation    0    0
  Scars               0    0
  No side effects     28   93.3
  Total               30   100

Discussion {#sec1-4}
==========

The associated factors are affecting the efficiency of the QS Alexandrite laser treatment.

Alex TriVantage laser is a Q-switched Alexandrite laser with the addition of 1064, 532 and 755 nm. Composing of 755 nm Long-Pulse mode, Alex TriVantage laser is used for treating a wide variety of epidermal and subdermal pigmented lesions safely. The Alexandrite allows deep penetrating rays in the skin to destroy melanocytes selectively while limiting post hyperpigmentation.

Freckles are commonly found in skin types I-IV as small, poorly marginated, pale brown macules on sun-exposed skin areas. They are not dangerous for the health, but they cause mainly cosmetic troublesome. Nowadays, many pigmentation lasers have been used for treating freckles such as the 755 nm alexandrite, 694 nm ruby, 532 nm, and 1064 nm neodymium: YAG nanosecond lasers appear to be safe and effective modalities.

In our study, 30 patients with freckles treated 2 sections with power 5.0-6.0 j/cm^2^; spot size 3 mm, at week 0 and week 4. Three patients needed only 1 session of treatment for clearing the lesions, and 2/30 patients needed 2 sessions. No patients needed 3 sessions. After 12-weeks, 100% of patients had improvement. After 2 sessions of treatment, the very good and good degree was found with 63.3% as shown in [Table 2](#T2){ref-type="table"}.

The study of Jang KA *et al*. carried out a study with 197 patients, using the Q-switched alexandrite laser at 8-week intervals with 7.0 J/cm2, and they also demonstrated 100% patients had improvement with only 1.5 sections \[[@ref8]\]. It elicits that using the lower power with shorter time interval as in our study giving the similar results of Jang group \[[@ref8]\].

An alexandrite laser is one that uses an alexandrite crystal as the laser source for producing a specific wavelength of red light (755 nm). Q-switched Alexandrite lasers refer to the technique of making the laser produce a high-intensity beam in very short pulses. Thus alexandrite lasers work by process of photothermolysis for melanin destruction.

Comparing between section 1 and 2, we noted that there was a statistically significant difference in colour's improvement (p \< 0.05). Although freckles do not have an increased number of the melanin-producing cells or melanocytes, freckles may instead of having melanocytes that overproduce melanin granules (melanosomes) changing the colouration of the outer skin cells (keratinocytes). Some other studies also demonstrated the improving after 1 to 3 lasers sessions in the treatment of pigmentation disorders \[[@ref10]\], \[[@ref11]\].

We used the VISIA machine to evaluate the efficacy of treatment. Brown Spots index supported us to assess the excessive concentration of melanin in freckle lesions. Brown spots index before and after treatment were 39.13 ± 20.66 and 53.23 ± 16.78 respectively; the difference is statistically significant with p \< 0.05.

Regarding factors such as age, skin type, our study showed that people less than 30 years old, and early onset before the age of 30 had good improvement with 77.8% and 66.7% respectively. The improvement is better for young people. Then there was a noticeable reduction in sebum secretion, skin dehydration and pigmentation.

The improvement of lesions located in the chin, nose and forehead area was 87.5%; 50% and 57.9% respectively. In the present study, there were only 2 patients, accounting for 6.7%, with post-inflammatory hyperpigmentation, as a side effect. This is similar to other studies in Asia \[[@ref8]\], \[[@ref9]\], \[[@ref12]\]. Our findings, as well as the results of other investigations, noted that post-inflammatory hyperpigmentation was temporary, resolving within one month, and no long-term complications were noted.

Also, we also founded no patients presented hypopigmentation, keloids, atrophic scars, keloids, atrophic scars and ochronosis. It was noted that there were no recurrences after 12 weeks.

In conclusion, laser QS -- Alexandrite had a good device for freckles treatment. All of the patients had improvement in lesion's colour, about 63.3% of patients with a very good and good level of improvement. Only 6.7% of patients had temporally post-inflammatory hyperpigmentation. The Q-switched alexandrite laser is a safe and highly effective modality for removing freckles without scarring or permanent pigmentary changes in Vietnamese skin.
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